HutchMED (China) LIMITED Increase (Decrease) in Accounts Receivable
HutchMED (China) LIMITED (HMDCF) reported Increase (Decrease) in Accounts Receivable of -$28.86 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-03-05
- HutchMED (China) LIMITED increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was $112.00K, a 91.82% decline year-over-year.
- HutchMED (China) LIMITED increase (decrease) in accounts receivable for the quarter ending 2019-09-30 was -$2.40M.
- HutchMED (China) LIMITED increase (decrease) in accounts receivable for the quarter ending 2019-06-30 was $420.00K, a 37.25% increase year-over-year.
- HutchMED (China) LIMITED increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was $2.14M, a 62.73% decline year-over-year.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$28.86M 20-F · filed 2026-03-05 | |||||
| 2025-06-30 | -$8.60M 6-K · filed 2025-08-07 | |||||
| 2024-12-31 | $38.55M 20-F · filed 2026-03-05 | |||||
| 2024-06-30 | $39.88M 6-K · filed 2025-08-07 | |||||
| 2023-12-31 | $21.34M 20-F · filed 2026-03-05 | |||||
| 2023-06-30 | $31.35M 6-K · filed 2024-07-31 | |||||
| 2022-12-31 | $14.45M 20-F · filed 2025-03-19 | |||||
| 2022-06-30 | -$6.40M 6-K · filed 2023-07-31 | |||||
| 2021-12-31 | $35.63M 20-F · filed 2024-02-28 | |||||
| 2021-06-30 | $10.94M 6-K · filed 2022-08-01 | $11.23M 6-K · filed 2021-07-28 | ||||
| 2020-12-31 | $4.69M 20-F · filed 2023-02-28 | $5.32M 20-F · filed 2021-03-04 | ||||
| 2020-06-30 | $3.21M 6-K · filed 2021-07-28 | |||||
| 2019-12-31 | $112.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$2.29M derived: sum of 2 quarters · filed 2022-03-03 | -$1.87M derived: sum of 3 quarters · filed 2022-03-03 | $271.00K 20-F · filed 2022-03-03 | $1.21M 20-F · filed 2020-03-03 | |
| 2019-09-30 | -$2.40M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$1.98M derived: sum of 2 quarters · filed 2020-07-30 | $159.00K 6-K · filed 2020-01-21 | $1.53M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | $420.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $2.56M 6-K · filed 2020-07-30 | $3.93M derived: sum of 3 quarters · filed 2021-03-04 | -$1.93M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $2.14M 6-K · filed 2019-06-06 | $3.51M derived: sum of 2 quarters · filed 2021-03-04 | -$2.35M derived: sum of 3 quarters · filed 2021-03-04 | -$2.04M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2018-12-31 | $1.37M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$4.49M derived: sum of 2 quarters · filed 2021-03-04 | -$4.18M derived: sum of 3 quarters · filed 2021-03-04 | $1.56M 20-F · filed 2021-03-04 | ||
| 2018-09-30 | -$5.86M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$5.55M derived: sum of 2 quarters · filed 2020-01-21 | $195.00K 6-K · filed 2020-01-21 | |||
| 2018-06-30 | $306.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $6.05M 6-K · filed 2019-07-30 | ||||
| 2018-03-31 | $5.75M 6-K · filed 2019-06-06 | |||||
| 2017-12-31 | -$2.16M 20-F · filed 2020-03-03 | |||||
| 2017-06-30 | $2.70M 6-K · filed 2018-07-27 | |||||
| 2016-12-31 | $7.26M 20-F · filed 2019-03-11 | |||||
| 2016-06-30 | $2.56M 6-K · filed 2017-07-31 | |||||
| 2015-12-31 | $12.03M 20-F · filed 2018-03-12 | |||||
| 2014-12-31 | -$8.29M 20-F · filed 2017-03-13 |